Genetic mouse models of Parkinson’s disease
Authors:
- Marie-Françoise ChesseletMCMarie-Françoise Chesselet
- 1 January 2010
- book chapter
- Published by Elsevier
- Vol. 184, 53-87
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathiesExperimental Neurology, 2010
- Forebrain overexpression of α-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruptionExperimental Neurology, 2010
- Mutant α-Synuclein Overexpression Mediates Early Proinflammatory ActivityNeurotoxicity Research, 2009
- Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or ParkinExperimental Neurology, 2009
- Genomewide association study for susceptibility genes contributing to familial Parkinson diseaseHuman Genetics, 2008
- Impaired learning and memory in Pitx3 deficient aphakia mice: A genetic model for striatum-dependent cognitive symptoms in Parkinson's diseaseNeurobiology of Disease, 2008
- Transcriptional dysregulation in a transgenic model of Parkinson diseaseNeurobiology of Disease, 2008
- Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expressionSynapse, 2007
- Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in miceNeurobiology of Disease, 2006
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005